AKT1 and metabolic dysfunction-associated steatotic liver disease: In this regard, the celecoxib‐induced inhibition of AKT Thr308 phosphorylation might be indifferent if it occurred in NAFLD manifested in diabetes mellitus featuring insulin resistance.